帮我润色这段学术论文ER is widely distributed in the genital organs of both sexes heart brain kidney bone and other organs and ER-specific binding sites are also present in a variety of tumor tissues including h

ER is widely distributed throughout the body, including in the genital organs of both sexes, heart, brain, kidney, bone, and other organs. ER-specific binding sites are also present in a variety of tumor tissues, such as breast, liver, ovarian, endometrial, and prostate cancers. The expression and distribution of ER in different tissues are influenced by various factors, including disease, gender, and age. For instance, studies have shown that both ERα and ERβ expression is upregulated in tissues when there is an increased stress load on the human heart.

ER is typically located in the cell membrane, cytoplasm, or nucleus of target organs, such as the breast and uterus. It binds to estrogen and nuclear receptors, triggering a range of regulatory mechanisms to regulate the transcription of downstream genes. The nuclear pathway, known as nuclear-initiated steroid signaling (NISS), involves estrogen binding to ERα or ERβ and the complex translocating sequentially to the nucleus. It then binds to ERE elements on DNA and activates ERE-dependent gene expression. In contrast, the non-classical membrane pathway, known as membrane-initiated steroid signaling (MISS), involves estrogen acting as a signal transducer via novel G protein-coupled receptors (GPCRs) on the plasma membrane. This rapidly activates and affects downstream transcription factors through various signaling pathways